Biopathies
The term "Biopathy" was introduced by Wilhelm Reich to indicate a process of decline in all energetic functions within the human organism. A limited or very weak pulsation, absorption capacity and orgone retention characterize the general picture up to the point where the organism balances with the surrounding orgone charge and dies (Reich, 1986).
​
Navarro (2001) divided biopathies according to the energetic charge of the biosystem into:
-
hypoorgonotic (with low energetic level)
-
hyperorgonotic (with a chronic surplus of energy that due to blocks in the energetic flow can more easily produce dor in the organism)
​
In an article, Dr. Alberto Foglia (2004) describes two cases of hyperthyroidism treated with orgone therapy. In one case he also uses the DB positioned directly on the thyroid area as a convergent instrument. Although the article does not mention the duration of the treatment, the immediate effect of the DB was to produce a very strong anxiety that the therapist subsequently dissolved with massage and orgone therapy. The author concludes that the DB, at the end of the therapy, had helped in some way.
Cancer
To better understand the development of this biopathy, Kavouras' team has differentiated three phases of the process:
-
Phase of absence of tumor mass characterized by energetic weakness that is denoted by the absence or scarcity of symptoms. If present, they are chronic symptoms. Acute diseases take a long time to heal with absence or low fever. The Reich blood test shows a rapid breakdown of red blood cells and the presence of T bacilli. Reduction of the Erythrocyte Sedimentation Rate (ESR). Treatment with ORAC can help improve general conditions and even develop a healing fever.
-
The tumor mass appears, often accompanied by pain in the area of ​​development. Reduction of strength and increase in physical exhaustion. T reaction (breakdown of red blood cells into T bacilli) and increased ESR. Normally, at this point, classical therapies are started.
There are three possible hypotheses:
-
The patient can return to phase 1 by integrating the daily use of ORAC​ (it is recommended to install one at home). Kavouras and other doctors report that in all cases where ORAC was used, no metastases were produced.
-
The patient remains in this phase without energy recharging and therapeutic work on bioenergetic resignation. The quality of life temporarily improves after classical treatments. A relapse occurs after 2-7 years.
-
The patient passes to phase 3 losing a lot of energy due to the presence of the tumor, the operation, chemotherapy or radiotherapy. Evidently, this is a general situation of low energy level which is influenced by age, lifestyle, emotional blocks and ontogenetic factors.
3. The final phase is marked by a rapid loss of energy, an increase in pain. This usually occurs within a maximum of two years after an operation of a relapse. The ESR rises to 40/80 mm. The T reaction is very rapid. There are metastases and relapses that occur rapidly. Various pains. Orgone irradiation in these cases has proven to be helpful in reducing or eliminating pain. In rare cases where assiduous therapeutic work has been combined with good patient motivation, it is possible to return to the previous phases.​​
Vecchietti (2017) explains the process of development of the cancer cell in two phases, the first of which is characterized by the following five stages:
-
Vesicular disintegration (bionose) of healthy cells.
-
Reorganization/aggregation of vesicles.
-
Formation of a membrane around the vesicular aggregate and beginning of its transformation into a cancer cell.
-
Evolution, complete separation and release into circulation of the cancer cell which acquires the classic club shape. Up to this phase, classical medicine tests do not detect any tumor process that will follow shortly.
-
Formation of the tumor mass.
The death of cancer cells begins the second phase in which enormous quantities of T bacilli are produced which continue to intoxicate the organism and promote further vesicular disintegration. As long as the body can keep the level of T bacilli, which is always produced in the organism as a byproduct of putrefaction/decomposition, under control, the organism continues to live in sufficiently good conditions. When the disintegration of the tumor (following classical treatments or with other therapies such as using ORAC) produces an excessive amount of T bacilli, the organism is heading towards death. For this reason, it must be taken into account that the disintegration of a tumor can temporarily improve the general condition, but the organism can subsequently be subjected to excessive intoxication by T bacilli.
Reich had already observed this problem and supported the hypothesis that a surgical removal of the tumor followed by treatment with ORAC could possibly solve the problem. Kavouras (2005) in this regard observes that the use of DB can help eliminate the T bacilli since they are the biophysical expression of the dor released with the dissolution of the tumor; this would avoid an overload of the excretory organs.
It is clear that the energy level of the person plays a very important role because the more vital the organism is, the better it will be able to face all the phases of the cancer process. The energy level also influences the capacity to charge inside the orgone accumulator which can be less intense than the dissolution of the tumor and encourage even more intoxication.
​Kavouras (2005) in this regard and to increase safety during treatment with cancer patients and low energy level usually adopts one of the following methods:
-
Treat with ORAC after DB;
-
Treat with ORAC before and after DB;
-
Treat with DB inside ORAC.​
A more detailed assessment of the general situation during treatments can be obtained by regularly performing Reich blood tests and ESR.​​
Foglia, A : Medical Orgone Therapy and the Medical DOR-buster in the Treatment of Graves' Disease, in “The Journal of Orgonomy” Vol. 38 N. 2, 2004.
Kavouras, J : Heilen mit Orgonenergie. Bietigheim: Turm Verlag, 2005.
Navarro, F: Somatopsicodinamica delle biopatie, IFeN, 2001.
Reich, W : La biopatia del cancro La scoperta dell’orgone. Vol. 2. SugarCo Edizioni, Milano, 1986.
Vecchietti, A : Il cancro spiegato dal punto di vista orgonomico, www.cellulacancerosa.it, 2017.​